• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Amevive (alefacept)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – May 2012

 

Summary View

 

6 ADVERSE REACTIONS

6.3 Postmarketing Experience
  • sections added ..... malignancies and serious infections

MEDICATION GUIDE

  • new